COBAS AMPLIPREP / COBAS AMPLICOR HCV TEST, V2.0 CE-IVD 03576698190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2014-03-19 for COBAS AMPLIPREP / COBAS AMPLICOR HCV TEST, V2.0 CE-IVD 03576698190 manufactured by Roche Molecular Systems.

Event Text Entries

[4289552] A customer site in (b)(6) filed a complaint alleging that discrepant hcv results were generated for one patient sample when tested with the cobas ampliprep / cobas amplicor (cap/ca) hcv test, v2. 0. On (b)(6)-2014, the test generated a (b)(6) hcv result. When repeated on (b)(6)-2014, the result was hcv (b)(6). The customer stated that the patient previously tested (b)(6) with the cap/ca hcv test, v2. 0 on (b)(6)-2013, although no data was provided for that sample. The patient's hcv titer is unknown and it is unknown if they are on treatment.
Patient Sequence No: 1, Text Type: D, B5


[11668848] A definitive conclusion cannot be drawn at this time, as the investigation into this issue is ongoing. The outcome of this investigation will be communicated through a follow-up report. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[34902925] Date of report 4/8/2014. Date received by manufacturer 4/8/2014. Device evaluated by manufacturer: yes. Result: device performed according to specifications. Conclusion: no failure detected and product within specification. The patient tested (b)(6) on (b)(6) 2013. A new sample from the same patient was collected on (b)(6) 2014 and generated a (b)(6) result. The same sample was tested on (b)(6) 2014, along with the first sample and both generated (b)(6) results. Additional information was received that genotyping was also performed on the patient sample collected (b)(6) 2014 with the siemen's lipa test on (b)(6) 2014 , but the result was very weak and was determined by the physician to be (b)(6). Subsequent testing of the older sample from (b)(6) 2013 generated a result of (b)(6). Analysis of raw data submitted by the customer indicated that the (b)(6) result generated on (b)(6) 2014 did not show any signs of pcr inhibition that could have led to the (b)(6) result. The (b)(6) target signal of the (b)(6) 2014 (b)(6) result was robust. , eliminating the possibility of the (b)(6) result having been due to a low amount of (b)(4) target material in the sample. It is possible that a sample mix-up could have occurred but that cannot be confirmed. Although requested, the complaint sample was not available for investigative testing. Testing of the complaint kit lot met specifications. Based on the information available, there is no indication of a product non-conformance. The cause of the (b)(6) result generated with the cap/ca (b)(4) test cannot be determined. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2243471-2014-00004
MDR Report Key3689192
Report Source01,05
Date Received2014-03-19
Date of Report2014-04-08
Date of Event2014-01-24
Date Mfgr Received2014-04-08
Date Added to Maude2014-05-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactVINCENT STAGNITTO
Manufacturer Street1080 US HWY 202 S
Manufacturer CityBRANCHBURG NJ 088763733
Manufacturer CountryUS
Manufacturer Postal088763733
Manufacturer Phone9082537569
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLIPREP / COBAS AMPLICOR HCV TEST, V2.0 CE-IVD
Generic NameASSAY,HYBRIDIZATION AND/OR NUCLEIC ACID AMPLIFICATION FOR DETECTION OF HCV
Product CodeMZP
Date Received2014-03-19
Catalog Number03576698190
Lot NumberS06949
Device Expiration Date2014-05-31
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HW 202S BRANCHBURG NJ 08876373 US 08876 3733


Patients

Patient NumberTreatmentOutcomeDate
10 2014-03-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.